Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment.

Mason, AJ; Gonzalez-Maffe, J; Quinn, K; Doyle, N; Legg, K; Norsworthy, P; Trevelion, R; Winston, A; Ashby, D; (2016) Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment. Statistics in medicine, 36 (5). pp. 754-771. ISSN 0277-6715 DOI:

Text - Published Version

Download (1MB) | Preview
Text - Supplemental Material

Download (57kB) | Preview


: The design of phase I studies is often challenging, because of limited evidence to inform study protocols. Adaptive designs are now well established in cancer but much less so in other clinical areas. A phase I study to assess the safety, pharmacokinetic profile and antiretroviral efficacy of C34-PEG4 -Chol, a novel peptide fusion inhibitor for the treatment of HIV infection, has been set up with Medical Research Council funding. During the study workup, Bayesian adaptive designs based on the continual reassessment method were compared with a more standard rule-based design, with the aim of choosing a design that would maximise the scientific information gained from the study. The process of specifying and evaluating the design options was time consuming and required the active involvement of all members of the trial's protocol development team. However, the effort was worthwhile as the originally proposed rule-based design has been replaced by a more efficient Bayesian adaptive design. While the outcome to be modelled, design details and evaluation criteria are trial specific, the principles behind their selection are general. This case study illustrates the steps required to establish a design in a novel context. Copyright © 2016 John Wiley & Sons, Ltd.<br/>

Item Type: Article
Faculty and Department: Faculty of Public Health and Policy > Dept of Health Services Research and Policy
PubMed ID: 27891651
Web of Science ID: 393303200003


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item